Among those at the meeting were Malvinder Singh; Tejendra Khanna, then Ranbaxy Board Chairman and Brian Tempest, then CEO. Mails sent to Daiichi Sankyo did not elicit a response. I urged the management and Mr Singh to remedy the problems and to tell DS (Daiichi Sankyo) the truth, but he refused. Both were in touch with Daiichi Sankyo though the entire duration of the sale process and the subsequent handholding phase but did not reveal anything about it to the new owners. # Daiichi did not have a clue about SAR because Ranbaxy top brass withheld the report and its significance.

Source: Indian Express August 10, 2016 23:12 UTC